Position in ROIV
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$344,034
New position
Shares Held
12,420
first reported quarter
Ownership
0.002%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 0.ToString("F0")%
Shared 0.ToString("F0")%
None 100.ToString("F0")%
Position in Biotechnology
Healthcare · as of Mar 31, 2026Sivia Capital Partners, LLC holds $4,485,324 across 9 Biotechnology names. ROIV ranks #6 (7.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BMRN |
Biomarin Pharmaceutical Inc
|
18,420 | $1,040,545 | |
| 2 | EXEL |
Exelixis, Inc.
|
23,984 | $1,028,673 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
4,438 | $839,003 | |
| 4 | INCY |
Incyte Corp
|
5,658 | $532,530 | |
| 5 | RPRX |
Royalty Pharma plc
|
7,479 | $358,767 | |
| 6 | ROIV |
Roivant Sciences Ltd.
This page
|
12,420 | $344,034 | |
| 7 | SVRA |
Savara Inc
|
48,500 | $264,810 | |
| 8 | ZNTL |
Zentalis Pharmaceuticals, Inc.
|
20,000 | $46,800 |
All Filings in ROIV
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $344,034 | 12,420 | Shares | Sole | 2026-05-13 | |
| No filing history on record for this holder in this stock. | ||||||